Castle Biosciences, Inc. (CSTL)
NASDAQ · Healthcare
Castle Biosciences, Inc. Gross Profit 2018–2025
Castle Biosciences, Inc. annual/quarterly gross profit history and growth rate from 2018 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Castle Biosciences, Inc. gross profit for the quarter ending March 31, 2026 was 63.1 M, a 11.81% decrease year-over-year.
- Castle Biosciences, Inc. gross profit for the twelve months ending March 31, 2026 was 267.7 M, a 6.25% increase year-over-year.
- Castle Biosciences, Inc. annual gross profit for 2025 was 273.2 M, a 0.49% increase from 2024.
- Castle Biosciences, Inc. annual gross profit for 2024 was 271.9 M, a 55.52% increase from 2023.
- Castle Biosciences, Inc. annual gross profit for 2023 was 174.8 M, a 66.43% increase from 2022.
- Castle Biosciences, Inc. annual gross profit for 2022 was 105.0 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Castle Biosciences, Inc. Gross Profit — FAQ
Castle Biosciences, Inc. (CSTL) gross profit over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Castle Biosciences, Inc.'s gross profit?
Castle Biosciences, Inc. (CSTL) reported gross profit of $273M for fiscal 2025.
Where can I see CSTL's gross profit history?
The chart and table above show Castle Biosciences, Inc.'s gross profit by year and by quarter, including the growth rate.